Read More Pharma Industry News Oscotec reports positive results from cevidoplenib phase 2 trial in ITP Oscotec has reported positive results from the phase 2 clinical trial of its SYK inhibitor cevidoplenib in patients… byPallavi MadhirajuFebruary 24, 2023